Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice

World Journal of Microbiology and Biotechnology

Volumn 29, Issue 5, 2013, Pages 907-913

  Jain, Shikha ^a   Afley, Prachiti ^a   Kumar, Subodh ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Brucella; Cysteine synthase A; IFN gamma; Subunit vaccine

Indexed keywords

AFFINITY CHROMATOGRAPHY; ALUMINUM HYDROXIDE; AMINO ACIDS; ESCHERICHIA COLI; IMMUNIZATION; PURIFICATION; VACCINES;

ALUMINIUM HYDROXIDE GELS; BRUCELLA; CYSTEINE SYNTHASE; IFN-GAMMA; IMMUNOLOGICAL RESPONSE; METAL-AFFINITY CHROMATOGRAPHY; PROTECTIVE EFFICACY; SUBUNIT VACCINE;

MAMMALS;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; ESCHERICHIA COLI; MUS;

EID: 84875743836     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-012-1247-3     Document Type: Article

References (35)

1. Ackerley DF, Barak Y, Lynch SV, Curtin J, Matin A (2006) Effect of chromate stress on Escherichia coli K-12. J Bacteriol 188: 3371-3381.
2. Araya LN, Winter AJ (1990) Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun 58: 254-256.
3. Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, Weyant R, Bragg SL, Spiegel RA, Tappero J, Perkins BA (2004) Adverse events in humans associated with accidental exposure to livestock brucellosis vaccine RB51. Vaccine 22: 3435-3439.
4. Baldwin CL, Goenka R (2006) Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 26: 407-442.
5. Blasco JM, Díaz R (1993) Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 342: 805.
6. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
7. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6: 3767-3780.
8. Corbel MJ (1997a) Brucellosis: an overview. Emerg Infect Dis 3: 213-221.
9. Corbel MJ (1997b) Vaccines against bacterial zoonoses. J Med Microbiol 46: 267-269.
10. Eze MO, Yuan L, Crawford RM, Paranavitana CM, Hadfield TL, Bhattacharjee AK, Warren RL, Hoover DL (2000) Effects of opsonization and gamma interferon on growth of Brucella melitensis 16 M in mouse peritoneal macrophages in vitro. Infect Immun 68: 257-263.
11. Franco MP, Mulder M, Gilman RH, Smits HL (2007) Human brucellosis. Lancet Infect Dis 7: 775-786.
12. Hansson M, Nygren P, Stahl S (2000) Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 32: 95-107.
13. Jaques I, Cloeckaert A, Linet JN, Dubray G (1992) Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J Med Microbiol 37: 100-103.
14. Kumar S, Balakrishna K, Agarwal GS, Merwyn S, Rai GP, Batra HV, Sardesai AA, Gowrishankar J (2009) Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model. Antonie van Leeuwenhoek 95: 91-100.
15. Liljeqvist S, Stahl S (1999) Production of recombinant subunit vaccine: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73: 1-33.
16. Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103: 511-518.
17. Noviello S, Gallo R, Kelly M, Limberger RJ, DeAngelis K, Cain L, Wallace B, Dumas N (2004) Laboratory-acquired brucellosis. Emerg Infect Dis 10: 1848-1850.
18. Oliveira SC, Harms JS, Rech EL, Rodarte RS, Bocca AL, Goes AM, Splitter GA (1998) The role of T cell subsets and cytokines in the regulation of an intracellular bacterial infection. Braz J Med Biol Res 32: 77-84.
19. Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med 352: 2325-2336.
20. Pappas G, Panagopoulou P, Christou L, Akritidis N (2006a) Brucella as a biological weapon. Cell Mol Life Sci 63: 2229-2236.
21. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV (2006b) The new global map of human brucellosis. Lancet Infect Dis 6: 91-99.
22. Paranavitana C, Zelazowska E, Izadjoo M, Hoover D (2005) Interferon-γ associated cytokines and chemokines produced by spleen cells from Brucella-immune mice. Cytokine 30: 86-92.
23. Perkins SD, Smither SJ, Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34: 379-394.
24. Rafiei A, Ardestani SK, Kariminia A, Keyhani A, Mohraz M, Amirkhani A (2006) Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J Infect 53: 315-324.
25. Roitt J, Brostoff J, Male D (2001) Immunology. Mosby Publications, London.
26. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, Vol. 1, 3rd edn. CSHL press, New York.
27. Schurig GG, Roop RMII, Bagchi T, Boyle S, Buhrman D, Sriranganathan N (1991) Biological properties of RB51: a stable rough strain of Brucella abortus. Vet Microbiol 28: 171-188.
28. Schurig GG, Sriranganathan N, Corbel MJ (2002) Brucellosis vaccines: past, present and future. Vet Microbiol 90: 479-496.
29. Stevens MG, Hennager SG, Olsen SC, Cheville NF (1994) Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J Clin Microbiol 32: 1065-1066.
30. Stevens MG, Olsen SC, Cheville NF (1995) Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or RB51. Vet Immunol Immunopathol 44: 223-235.
31. Tanous C, Soutourina O, Raynal B, Hullo MF, Mervelet P, Gilles AM, Noirot P, Danchin A, England P, Martin-Verstraeteal I (2008) The CymR regulator in complex with the enzyme CysK controls cysteine metabolism in Bacillus subtilis. J Biol Chem 283: 35551-35560.
32. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46: e131-e136.
33. Wu R, Sun Z, Wu J, Meng H, Zhang H (2010) Effect of bile salts stress on protein synthesis of Lactobacillus casei Zhang revealed by 2-dimensional gel electrophoresis. J Dairy Sci 93: 3858-3868.
34. Xiang Z, Todd T, Ku KP, Kovacic BL, Larson CB, Chen F, Hodges AP, Tian Y, Olenzek EA, Zhao B, Colby LA, Rush HG, Gilsdorf JR, Jourdian GW, He Y (2008) VIOLIN: vaccine investigation and online information network. Nucleic Acids Res 36: D923-D928.
35. Young EJ (1994) An overview of human brucellosis. Clin Infect Dis 21: 283-289.